Cite Filings / DMRA / 0000950170-23-015475

Feed Companies Filings Check

Sign in

DEF 14A

Proxy Statement

Damora Therapeutics, Inc. Filed 2023-04-28 Acc 0000950170-23-015475

Documents 1

DEF 14A Proxy Statement , glto-2023-def_14a.htm

Around this filing

2024-04-29 DEF 14A Proxy Statement
2023-04-28 ARS Annual Report to Security Holders
2023-04-28 DEFA14A Proxy Materials
2023-04-28 DEF 14A Proxy Statement
2023-04-28 10-Q Quarterly Report
2022-04-28 DEF 14A Proxy Statement

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading glto-2023-def_14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…